The Medicare Access and CHIP Reauthorization Act

Effects on Medicare

Published in: Health Affairs 36, no.4 (April 2017):697-705. doi: 10.1377/hlthaff.2016.0559

Posted on RAND.org on April 05, 2017

by Peter S. Hussey, Jodi L. Liu, Chapin White

Read More

Access further information on this document at Published in: Health Affairs 36

This article was published outside of RAND. The full text of the article can be found at the link above.

In 2015, Congress repealed the Sustainable Growth Rate formula for Medicare physician payment, eliminating mandatory payment cuts when spending exceeded what was budgeted. In its place, Congress enacted the Medicare Access and CHIP Reauthorization Act (MACRA), which established a two-track performance-based payment system that encourages physicians to participate in alternative payment models. MACRA could have huge effects on health care delivery, but the nature of those effects is highly uncertain. Using the RAND Corporation's Health Care Payment and Delivery Simulation Model, we estimated the effects of MACRA on Medicare spending and utilization and examined how effects would differ under various scenarios. We estimate that MACRA will decrease Medicare spending on physician services by –$35 to –$106 billion (–2.3 percent to –7.1 percent) and change spending on hospital services by $32 to –$250 billion (0.7 percent to –5.1 percent) in 2015–30. The spending effects are critically dependent on the strength of incentives in the alternative payment models, particularly the incentives for physicians to reduce hospital spending and physician responses to MACRA payment rates.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.